KANDA GILES: Open Payments
NPI 1073187506 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 22 payments from 7 companies in 2025. Trend: 2023 $37 · 2024 $4,377 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $221 |
| SCPHARMACEUTICALS INC. | 4 | $88 |
| Fresenius USA Marketing, Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| AKEBIA THERAPEUTICS INC | 2 | $54 |
| Amgen Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: IBSRELA, FUROSCIX, VELPHORO, Vanrafia, Fabhalta, Vafseo, Auryxia, TAVNEOS.
Industry payments across VA — which companies pay providers there.
